Lombard Medical, which offers innovative stent-grafts for highly angled endovascular aortic repair, raised $55 million by offering 5.0 million shares at $11. Lombard Medical plans to list on the NASDAQ under the symbol EVAR. Lombard Medical initially filed...read more
Lombard Medical, which offers innovative stent-grafts for highly angled endovascular aortic repair, revived plans for its upcoming IPO and lowered the proposed deal size on Wednesday. The Oxfordshire, United Kingdom-based company postponed its IPO in early April...read more
Lombard Medical, which offers innovative stent-grafts for highly angled endovascular aortic repair, postponed its IPO on Friday, citing poor market conditions. The Oxfordshire, United Kingdom-based company was founded in 2003 and booked $7 million in sales for...read more
Lombard Medical prices IPO at $11
Lombard Medical, which offers innovative stent-grafts for highly angled endovascular aortic repair, raised $55 million by offering 5.0 million shares at $11. Lombard Medical plans to list on the NASDAQ under the symbol EVAR. Lombard Medical initially filed...read more
Stent developer Lombard Medical revives IPO plans and decreases deal size
Lombard Medical, which offers innovative stent-grafts for highly angled endovascular aortic repair, revived plans for its upcoming IPO and lowered the proposed deal size on Wednesday. The Oxfordshire, United Kingdom-based company postponed its IPO in early April...read more
Lombard Medical postpones $60 million IPO
Lombard Medical, which offers innovative stent-grafts for highly angled endovascular aortic repair, postponed its IPO on Friday, citing poor market conditions. The Oxfordshire, United Kingdom-based company was founded in 2003 and booked $7 million in sales for...read more
16 US IPOs planned for the week of Apr 7
The following IPOs are expected to price this week: Adamas Pharmaceuticals (ADMS), which is developing treatments for CNS disorders such as Parkinson's and Alzheimer's, ...read more